Stocks to Watch for February 12, 2016
( click to enlarge )
Shares of Celldex Therapeutics, Inc. (NASDAQ:CLDX) closed the day gaining more than four percentage points on solid volume. The stock has dropped from $16.65 a share to $6.25 a share over the course of just two months. There are some signs of a possible bounce at this point due to oversold indicators and some positive divergences, which often leads to short covering. The Relative Strenght Index has reversed the course and the daily MACD is starting to curl up, suggesting that a positive crossover could be coming soon. I feel that this stock can easily run to 8.5's in the near term.
( click to enlarge )
ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) looks poised for a break to the upside. A minor resistance is expected at 5.65 (20EMA) but if that resistance fails, the further gains towards $5.99 will be expected. Technical indicators are looking neutral to bullish. The RSI is moving up and above its 40 level. The daily MACD continues to trade above its sginal line but in the negative territory and the CMF is now positive, which means there is some money flowing into the stock. Overall my short-term view remains neutral till a decisive break above $5.65 takes place.
( click to enlarge )
Intrexon Corp (NYSE:XON) has been pulling back on low volume while the Chaikin Money Flow continues to rise, signaling accumulation. I would not be surprised to see it test the $36 level again in the coming days.
Disclaimer : This is not an investment advisory, and should not be used to make investment decisions. Information in AC Investor Blog is often opinionated and should be considered for information purposes only. No stock exchange anywhere has approved or disapproved of the information contained herein. There is no express or implied solicitation to buy or sell securities. The charts provided here are not meant for investment purposes and only serve as technical examples. Don't consider buying or selling any stock without conducting your own due diligence.
Thanks for visiting AC Investor Blog.
AC
( click to enlarge )
Relypsa Inc (NASDAQ:RLYP) has sold off over the past few weeks but looks to have found a bottom. The stock closed up $1.42 Thursday on good volume. Daily MACD also gave a buy signal today. Let's keep an eye on it as i think momentum will pick up. First upside target of $19
If you want to contact me for advertising opportunities on blog or twitter, then get in touch via emailDisclaimer : This is not an investment advisory, and should not be used to make investment decisions. Information in AC Investor Blog is often opinionated and should be considered for information purposes only. No stock exchange anywhere has approved or disapproved of the information contained herein. There is no express or implied solicitation to buy or sell securities. The charts provided here are not meant for investment purposes and only serve as technical examples. Don't consider buying or selling any stock without conducting your own due diligence.
Thanks for visiting AC Investor Blog.
AC
